RhumbLine Advisers’s Third Harmonic Bio THRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $183K | Buy |
33,672
+5,501
| +20% | +$29.9K | ﹤0.01% | 3270 |
|
|
2025
Q1 | $97.7K | Sell |
28,171
-751
| -3% | -$2.61K | ﹤0.01% | 3403 |
|
|
2024
Q4 | $298K | Buy |
28,922
+202
| +0.7% | +$2.08K | ﹤0.01% | 2989 |
|
|
2024
Q3 | $389K | Buy |
28,720
+119
| +0.4% | +$1.61K | ﹤0.01% | 2877 |
|
|
2024
Q2 | $372K | Buy |
28,601
+7,940
| +38% | +$103K | ﹤0.01% | 2867 |
|
|
2024
Q1 | $195K | Buy |
20,661
+888
| +4% | +$8.38K | ﹤0.01% | 3196 |
|
|
2023
Q4 | $217K | Buy |
19,773
+1,145
| +6% | +$12.6K | ﹤0.01% | 3148 |
|
|
2023
Q3 | $119K | Buy |
18,628
+1,841
| +11% | +$11.8K | ﹤0.01% | 3400 |
|
|
2023
Q2 | $80.7K | Buy |
16,787
+4,885
| +41% | +$23.5K | ﹤0.01% | 3576 |
|
|
2023
Q1 | $49K | Buy |
11,902
+1,267
| +12% | +$5.22K | ﹤0.01% | 2909 |
|
|
2022
Q4 | $46K | Buy |
+10,635
| New | +$46K | ﹤0.01% | 2958 |
|